drugset / Trial / NCT01360424

Teriparatide Treatment in Patients With Inherited Osteoporosis

NCT01360424

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to analyse efficacy of teriparatide treatment in patients with new forms of inherited low-turnover osteoporosis.

Timeline

Start
2011-05
Primary completion
2013-11
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Teriparatide Protein / enzyme biologic 20 ug Subcutaneous

Indications